Federal Register / Vol. 65, No. 100 / Tuesday, May 23, 2000 / Notices 33353

In 1973, the Santee Greens site (CA

Sdi 5699) was excavated prior to

residential development by

Archaeological Consulting Technology,

Inc. (ACT) under contract with Time for

Living, Inc. ACT stored these cultural

items until 1998, when collections

including these cultural items were

donated to the San Diego Archaeological

Center, San Diego, CA. The human

remains recovered with these cultural

items were repatriated to the Cuyapaipe

Community of Degueno Mission Indians

of the Cuyapaipe Reservation in 1973.

Based on geographic location and

archeological evidence, the Santee

Greens site has been identified as a

Kumeyaay village site dating to the Late

Archaic period (c. 760–1030 A.D.).

Based on site information, excavation

records, and manner of interment, these

cultural items have been identified as

unassociated funerary objects.

Archeological literature and continuity

of occupation indicates cultural

affiliation with the Kumeyaay tribes.

Based on the above mentioned

information, officials of the San Diego

Archaeological Center have determined

that, pursuant to 43 CFR 10.2(d)(2)(ii),

these 11 cultural items are reasonably

believed to have been placed with or

near individual human remains at the

time of death or later as part of the death

rite or ceremony and are believed, by a

preponderance of the evidence, to have

been removed from a specific burial site

of an Native American individual.

Officials of the San Diego

Archaeological Center have also

determined that, pursuant to 43 CFR

10.2(e), there is a relationship of shared

group identity which can be reasonably

traced between these items and the

Campo Band of Diegueno Mission

Indians of the Campo Reservation, the

Capitan Grande Band of Diegueno

Mission Indians of California, the

Barona Group of Capitan Grande Band

of Mission Indians of the Barona

Reservation, the Viejas (Baron Long)

Group of Capitan Grande Band of

Mission Indians of the Viejas

Reservation, the Cuyapaipe Community

of Degueno Mission Indians of the

Cuyapaipe Reservation, the Inaja Band

of Diegueno Mission Indians of the Inaja

and Cosmit Reservation, the La Posta

Band of Diegueno Mission Indians of

the La Posta Reservation, the Manzanita

Band of Diegueno Mission Indians of

the Manzanita Reservation, the Jamul

Indian Village, the Mesa Grande Band of

Diegueno Mission Indians of the Mesa

Grande Reservation, the San Pasqual

Band of Diegueno Mission Indians of

California, the Santa Ysabel Band of

Diegueno Mission Indians of the Santa

Ysabel Reservation, and the Sycuan

Band of Diegueno Mission Indians of

California.

This notice has been sent to officials

of the Kumeyaay Cultural Repatriation

Committee, the Campo Band of

Diegueno Mission Indians of the Campo

Reservation, the Capitan Grande Band of

Diegueno Mission Indians of California,

the Barona Group of Capitan Grande

Band of Mission Indians of the Barona

Reservation, the Viejas (Baron Long)

Group of Capitan Grande Band of

Mission Indians of the Viejas

Reservation, the Cuyapaipe Community

of Degueno Mission Indians of the

Cuyapaipe Reservation, the Inaja Band

of Diegueno Mission Indians of the Inaja

and Cosmit Reservation, the La Posta

Band of Diegueno Mission Indians of

the La Posta Reservation, the Manzanita

Band of Diegueno Mission Indians of

the Manzanita Reservation, the Jamul

Indian Village, the Mesa Grande Band of

Diegueno Mission Indians of the Mesa

Grande Reservation, the San Pasqual

Band of Diegueno Mission Indians of

California, the Santa Ysabel Band of

Diegueno Mission Indians of the Santa

Ysabel Reservation, and the Sycuan

Band of Diegueno Mission Indians of

California. Representatives of any other

Indian tribe that believes itself to be

culturally affiliated with these objects

should contact Yvonne Lever, San Diego

Archaeological Center, 334 Eleventh

Ave., San Diego, CA 92101; telephone:

(619) 239–1868 before June 22, 2000.

Repatriation of these objects to the

Kumeyaay Cultural Repatriation

Committee on behalf of the Campo Band

of Diegueno Mission Indians of the

Campo Reservation, the Capitan Grande

Band of Diegueno Mission Indians of

California, the Barona Group of Capitan

Grande Band of Mission Indians of the

Barona Reservation, the Viejas (Baron

Long) Group of Capitan Grande Band of

Mission Indians of the Viejas

Reservation, the Cuyapaipe Community

of Degueno Mission Indians of the

Cuyapaipe Reservation, the Inaja Band

of Diegueno Mission Indians of the Inaja

and Cosmit Reservation, the La Posta

Band of Diegueno Mission Indians of

the La Posta Reservation, the Manzanita

Band of Diegueno Mission Indians of

the Manzanita Reservation, the Jamul

Indian Village, the Mesa Grande Band of

Diegueno Mission Indians of the Mesa

Grande Reservation, the San Pasqual

Band of Diegueno Mission Indians of

California, the Santa Ysabel Band of

Diegueno Mission Indians of the Santa

Ysabel Reservation, and the Sycuan

Band of Diegueno Mission Indians of

California may begin after that date if no

additional claimants come forward.

Dated: May 8, 2000.

Francis P. McManamon,

Departmental Consulting Archeologist,

Manager, Archeology and Ethnography

Program.

[FR Doc. 00–12850 Filed 5–22–00; 8:45 am]

BILLING CODE 4310–70–F

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated February 14, 2000,

and published in the Federal Register

on February 22, 2000, (65 FR 35), Isotec

Inc., 3858 Benner Road, Miamisburg,

Ohio 45342, made application by

renewal to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Cathinone (1235) .............................. I

Methcathinone(1237) ........................ I

N-Ethylamphetamine (1475) ............. I

N-N-Dimethylamphetamine (1480) ... I

Aminorex (1585) ................................ I

Methaqualone (2565) ........................ I

Lysergic acid diethylamide (7315) .... I

Tetrahydrocannabinols (7370) .......... I

Mescaline (7381) ............................... I

2,5-Dimethoxyamphetamine (7396) .. I

3,4-Methylenedioxyamphetamine

(7400).

I

3,4-Methylenedioxy-Nethylamphetamine (7404).I

3, 4,-

Methylenedioxymethamphetamine

(7405).

I

4-Methoxyamphetamine (7411) ........ I

Psilocybin (7437) ............................... I

Psilocyn (7438) ................................. I

N-Ethyl-1-phenylcyclohexylamine

(7455).

I

Dihydromorphine (9145) ................... I

Normorphine (9313) .......................... I

Acetylmethadol (9601) ...................... I

Alphacetylmethadol Except LevoAlphacetylmethadol (9603).I

Normethadone (9635) ....................... I

3-Methylfentanyl (9813) .................... I

Amphetamine (1100) ......................... II

Methamphetamine (1105) ................. II

Methylphenidate (1724) .................... II

Amobarbital (2125) ............................ II

Pentobarbital (2270) .......................... II

Secobarbital (2315) ........................... II

1-Phenylcyclohexylamine (7460) ...... II

Phencyclidine (7471) ......................... II

Phenylacetone (8501) ....................... II

1-Piperidinocyclohexanecarbonitrile

(8603).

II

Codeine (9050) ................................. II

Dihydrocodeine (9120) ...................... II

Oxycodone (9143) ............................. II

Hydromorphone (9150) ..................... II

Benzoylecgonine (9180) ................... II

33354 Federal Register / Vol. 65, No. 100 / Tuesday, May 23, 2000 / Notices

Drug Schedule

Ethylmorphone (9190) ....................... II

Hydrocodone (9193) ......................... II

Isomethadone (9226) ........................ II

Meperidine (9230) ............................. II

Methadone (9250) ............................. II

Methadone intermediate (9254) ........ II

Dextropropoxyphene, bulk (non-dosage forms) (9273).II

Morphine (9300) ................................ II

Levo-Alphacetylmethadol (9648) ...... II

Oxymorphone (9652) ........................ II

Fentanyl (9801) ................................. II

The firm plans to manufacture small

quantities of the listed controlled

substances to produce standards for

analytical laboratories.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Iostec, Inc. to

manufacture the listed controlled

substances is consistent with the public

interest at this time. DEA has

investigated the company on a regular

basis to ensure that its continued

registration is consistent with the public

interest. These investigations have

included inspection and testing of the

company’s physical security systems,

audits of the company’s records,

verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: May 12, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–12842 Filed 5–22–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By notice dated February 10, 2000,

and published in the Federal Register

on February 17, 2000, (65 FR 33),

Novartis Pharmaceutical Corporation,

59 Route 10, East Hanover, New Jersey

07926, made application by renewal to

the Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of methylphenidate

(1724), a basic class of controlled

substance listed in Schedule II.

The firm plans to manufacture

finished product for distribution to its

customers.

DEA has considered the factors in title

21, United States Code, section 823(a)

and determined that the registration of

Novartis Pharmaceutical Corporation to

manufacture methylphenidate is

consistent with the public interest at

this time. DEA has investigated Novartis

Pharmaceutical Corporation on a regular

basis to ensure that the company’s

continued registration is consistent with

the public interest. These investigations

have included inspection and testing of

the company’s physical security

systems, audits of the company’s

records, verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic class of controlled substance

listed above is granted.

Dated: May 12, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–12841 Filed 5–22–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title

21 of the Code of Federal Regulations

(CFR), this is notice that on March 30,

2000, Radian International LLC, 14050

Summit Drive #121, P.O. Box 201088,

Austin, Texas 78720–1088, made

application by renewal to the Drug

Enforcement Administration (DEA) for

registration as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

Cathinone (1235) .............................. I

Methcathinone (1237) ....................... I

N-Ethylamphetamine (1475) ............. I

N-N-Dimethylamphetamine (1480) ... I

Aminorex (1585) ................................ I

4-Methylaminorex (cis isomer)

(1590).

I

Methaqualone (2565) ........................ I

Drug Schedule

Alpha-Ethyltryptamine (7249) ............ I

Lysergic acid diethylamide (7315) .... I

Tetrahydrocannabinols (7370) .......... I

Mescaline (7381) ............................... I

3,4,5-Trimethoxyamphetamine

(7390).

I

4-Bromo-2,5-dimethoxyamphetamine

(7391).

I

4-Bromo-2,5-

dimethoxyphenethylamine (7392).

I

4-Methyl-2,5-dimethoxyamphetamine

(7395).

I

2,5-Dimethoxyamphetamine (7396) .. I

2,5-Dimethoxy-4-ethylamphetamine

(7399).

I

3,4-Methylenedioxyamphetamine

(7400).

I

5-Methoxy-3,4-

methylenedioxyamphetamine

(7401).

I

N-Hydroxy-3,4-

methylenedioxyamphetamine

(7402).

I

3,4-Methylenedioxy-Nethylamphetamine (7404).I

3,4-

Methylenedioxymethamphetamine

(7405).

I

4-Methoxyamphetamine (7411) ........ I

Bufotenine (7433) .............................. I

Diethyltryptamine (7434) ................... I

Dimethyltryptamine (7435) ................ I

Psilocybin (7437) ............................... I

Psilocyn (7438) ................................. I

Acetyldihydrocodeine (9051) ............. I

Benzylmorphine (9052) ..................... I

Codeine-N-oxide (9053) .................... I

Dihydromorphine (9145) ................... I

Heroin (9200) .................................... I

Morphine-N-oxide (9307) .................. I

Normorphine (9313) .......................... I

Pholcodine (9314) ............................. I

Acetylmethadol (9601) ...................... I

Allyprodine (9602) ............................. I

Alphacetylmethadol except LevoAlphacetylmethadol (9603).I

Alphameprodine (9604) ..................... I

Alphamethadol (9605) ....................... I

Betacetylmethadol (9607) ................. I

Betameprodine (9608) ...................... I

Betamethadol (9609) ......................... I

Betaprodine (9611) ........................... I

Hydromorphinol (9627) ..................... I

Noracymethadol (9633) ..................... I

Norlevorphanol (9634) ...................... I

Normethadone (9635) ....................... I

Trimeperidine (9646) ......................... I

Para-Fluorofentanyl (9812) ............... I

3-Methylfentanyl (9813) .................... I

Alpha-methylfentanyl (9814) ............. I

Acetyl-alpha-methylfentanyl (9815) ... I

Beta-hydroxyfentanyl (9830) ............. I

Beta-hydroxy-3-methyfentanyl (9831) I

Alpha-Methylthiofentanyl (9832) ....... I

3-Methylthiofentanyl (9833) ............... I

Thiofentanyl (9835) ........................... I

Amphetamine (1100) ......................... II

Methamphetamine (1105) ................. II

Phenmetrazine (1631) ....................... II

Methylphenidate (1724) .................... II

Amobarbital (2125) ............................ II

Pentobarbital (2270) .......................... II

Secobarbital (2315) ........................... II